HMGN1 and cancer: Given the relevance of epigenetic changes in establishing dormancy in breast cancer81 and our observation linking the expression levels of HMGN1 with the dormancy/awakening transition (Supplementary Fig. 10), targeting HMGN1-G4 with ligands might offer scope for the development of a therapeutic strategy to prevent the awakening of dormant cells and cancer relapse.